Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
US8507516B2 · kind B2 · utility
4Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 2010 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | May 12, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.